Monascus purpureus (Red Yeast Rice)

Alternative Medicine Review

Volumn 9, Issue 2, 2004, Pages 208-210

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PLACEBO; TRIACYLGLYCEROL; BIOLOGICAL PRODUCT; RED YEAST RICE;

BREAST FEEDING; CHEMICAL STRUCTURE; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; DYSLIPIDEMIA; FAT INTAKE; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIVER DISEASE; MAJOR CLINICAL STUDY; MONASCUS; MONASCUS PURPUREUS; NUTRIENT; PREGNANCY; RED YEAST RICE; REVIEW; RICE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; YEAST; ARTICLE;

BIOLOGICAL PRODUCTS; HUMANS; HYPERLIPIDEMIAS;

EID: 3042548708     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Li C, Zhu Y, Wang Y, et al. Monascus purpureus fermented rice (red yeast rice): A natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 1998;18:71-81.
2. Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999;69:231-236.
3. Man RY, Lynn EG, Cheung F, et al. Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Mol Cell Biochem 2002;233:153-158.
4. Bradford RH, Shear CL, Chremos AN, et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol 1994;74:667-673.
5. Wang J, Lu Z, Chi J, et al. Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Cur Ther Res 1997;58:964-978.
6. Rippe J, Bonovich K, Colfer H. A multi-center, self-controlled study of Cholestin™ in subjects with elevated cholesterol. 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. Orlando, FL: 1999; March 24-27:1123.
7. Qin S, Zhang W, Qi P, et al. Elderly patients with primary hyperlipidemia benefited from treatment with a Monascus purpureus rice preparation: a placebo-controlled, double-blind clinical trial. 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. Orlando, FL: 1999; March 24-27:1123.
8. Keithley JK, Swanson B, Sha BE, et al. A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition 2002;18:201-204.
9. Farmer JA, Torre-Amione G. Comparative tolerability of HMG-CoA-reductase inhibitors. Drug Safety 2000;23:197-213.
10. Mortom I, Hall J. The Avery Complete Guide to Medicines. New York, NY: Penguin Putnam; 2001:513-514.
11. Prasad GV, Wong T, Meliton G, Bhaloo S. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 2002;74:1200-1201.
12. Havel R. Dietary supplement or drug? The case of cholestin. Am J Clin Nutr 1999;69:175-176.
13. Heber D, Lembertas A, Lu QY, et al. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med 2001;7:133-139.